» Articles » PMID: 33221577

Rise of Levels of Von Willebrand Factor and Factor VIII with Age: Role of Genetic and Acquired Risk Factors

Overview
Journal Thromb Res
Date 2020 Nov 22
PMID 33221577
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Von Willebrand factor (VWF) levels are regulated by genetic and acquired factors. The acquired factors are mostly related to age and could be mediators of the age effect on VWF levels.

Objectives: To disentangle the role of genetic (sex, blood group) and acquired factors (comorbidities, body mass index, reduced kidney function, hormone use, and inflammation) in regulating von Willebrand factor antigen (VWF:Ag) and factor VIII activity (FVIII:C) levels in the normal population.

Methods: Analysis were performed in a large population sample (2923 individuals) from the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA study), after exclusion of individuals with active cancer and women who were pregnant or within nine months postpartum. The increase of VWF:Ag and FVIII:C with age was evaluated by linear regression after the age of 40 years. Analyses were adjusted for acquired factors and stratified for sex and blood group.

Results: VWF:Ag and FVIII:C increased with age: increase per decade of age for VWF:Ag 18 IU/dL (95%CI 15-20) and for FVIII:C 12 IU/dL (95%CI 10-14). After adjustment for acquired factors, the increase per decade was 13 IU/dL (95%CI 10-16) for VWF:Ag and 9 IU/dL (95%CI 6-11) for FVIII:C. The stratified analysis for blood group showed higher increase in the non-O group, but these differences were annulled after adjustment for acquired factors.

Conclusions: VWF:Ag and FVIII:C increase with age. Carriers of blood group non-O present a steeper increase of VWF:Ag and FVIII:C with age, that is mediated by acquired factors.

Citing Articles

Genetics and Epigenetics in Acquired Hemophilia A: From Bench to Bedside.

Evangelidis N, Kotsiou N, Evangelidis P, Alevizopoulos V, Dermitzakis I, Chissan S Curr Issues Mol Biol. 2024; 46(6):5147-5160.

PMID: 38920981 PMC: 11201880. DOI: 10.3390/cimb46060309.


Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor.

Spena S, Cairo A, Gianniello F, Pappalardo E, Mortarino M, Garagiola I Int J Mol Sci. 2023; 24(18).

PMID: 37762470 PMC: 10532311. DOI: 10.3390/ijms241814167.


RNA sequencing suggests that non-coding RNAs play a role in the development of acquired haemophilia.

Tigu A, Hotea I, Drula R, Zimta A, Dirzu N, Santa M J Cell Mol Med. 2023; 27(13):1790-1796.

PMID: 37317065 PMC: 10315746. DOI: 10.1111/jcmm.17741.


Alteration of plasma von Willebrand factor in the treatment of retinal vein occlusion with cystoid macular edema.

Hirai H, Yamashita M, Matsumoto M, Nishiyama T, Wada D, Okabe N PLoS One. 2022; 17(9):e0264809.

PMID: 36137144 PMC: 9499207. DOI: 10.1371/journal.pone.0264809.


Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer.

Focosi D, Rosellini A, Spezia P, Macera L, Lanza M, Paolicchi A J Clin Virol Plus. 2022; 1(3):100035.

PMID: 35262018 PMC: 8349435. DOI: 10.1016/j.jcvp.2021.100035.